Search

Your search keyword '"Montagna, Cristina"' showing total 591 results

Search Constraints

Start Over You searched for: Author "Montagna, Cristina" Remove constraint Author: "Montagna, Cristina"
591 results on '"Montagna, Cristina"'

Search Results

3. Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes

6. Age‐related telomere attrition causes aberrant gene expression in sub‐telomeric regions

7. A direct comparison of interphase FISH versus low-coverage single cell sequencing to detect aneuploidy reveals respective strengths and weaknesses.

8. Cytogenetic, Genomic, and Functional Characterization of Pituitary Gonadotrope Cell Lines

9. Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2.

10. MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism

12. Supplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

13. Data from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

14. Supplementary Methods, Results, Figures 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

15. Whole Chromosome Instability induces senescence and promotes SASP.

16. Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies

17. Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

22. Single-cell analysis of somatic mutation burden in mammary epithelial cells of pathogenic BRCA1/2 mutation carriers

33. Characterization of the HLA-F ligandome in T-cell lymphoma

34. An oncogenic isoform of septin 9 promotes the formation of juxtanuclear invadopodia by reducing nuclear deformability

35. Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolism

37. Data from RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors

38. Supplementary Figures 1 - 3 from RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors

39. Table S1 from Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein

40. Supplementary Figure 1 from Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein

41. Supplementary Figure 1 from An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression

42. Data from An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression

43. Supplementary Table 1 from An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression

44. Supplementary Figure 5 from An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression

45. Supplementary Figure 4 from An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression

46. Data from PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab

47. Supplementary Figures 1-5 from PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab

48. Supplementary Figure 3 from An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression

50. Supplementary Legends for Figures 1-5, Table 1 from An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression

Catalog

Books, media, physical & digital resources